Welcome Rosita, new MC3 Clinical Trial Coordinator
Clinical Trial Feature: IFx-Hu2.0 Followed By Pembrolizumab…
MC3 Memos Newsletter | Vol. 3 (October 2025)
2026 NCCN Guidelines
MC3 Member Spotlight: Isaac Brownell, MD, PhD
Haroldo Rodriguez Successfully Defends PhD Dissertation